Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00858858 · ClinicalTrials.gov registry record · NA
Clinical Studies on Bile Acids in Barrett's Esophagus
A NA study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT00858858 is a NA study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 60 participants.
The verdict
NCT00858858, a NA study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This study has two major goals: 1. To determine the effects of bile salts on causing DNA injury and activating signaling pathways that promote growth in cells from the esophagus of patients who have gastroesophageal reflux disease (GERD) 2. To determine whether changes in bile composition induced by treating patients with a bile salt called ursodeoxycholic acid (UDCA) can alter DNA injury, signaling pathway activation and other types of damage in cells from the esophagus of patients who have GERD.
Interventions
- DRUG Ursodeoxycholic Acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2009-03 |
| Est. Completion | 2015-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00858858
The ClinicalTrials.gov registry entry for NCT00858858 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ursodeoxycholic Acid is the first listed.
NCT00858858 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00858858 about?
NCT00858858 is a clinical study titled "Clinical Studies on Bile Acids in Barrett's Esophagus". This study has two major goals: 1. To determine the effects of bile salts on causing DNA injury and activating signaling pathways that promote growth in cells from the esophagus of patients who have gastroesophageal reflux disease (GERD) 2. To determine whether changes in bile composition induced b...
What is the current status of trial NCT00858858?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2009-03. Estimated completion is 2015-02.
What interventions are being tested in trial NCT00858858?
The interventions under investigation include: Ursodeoxycholic Acid (DRUG).
Who is sponsoring clinical trial NCT00858858?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.